Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

Elicera Therapeutics AB

Closing information (x1000 SEK)

Closing information 2023/12 2022/12 2021/12
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 76 More Arrow 129 Less Arrow 0
Earnings before taxes -16,398 Less Arrow -19,439 More Arrow -2,823
EBITDA -17,084 Less Arrow -19,351 More Arrow -2,817
Total assets 30,180 More Arrow 46,308 More Arrow 54,738
Current assets 30,167 More Arrow 45,800 More Arrow 54,219
Current liabilities 13,779 Less Arrow 13,509 Less Arrow 2,500
Equity capital 16,401 More Arrow 32,799 More Arrow 52,238
- share capital 831 Equal arrow 831 Equal arrow 831
Employees (average) 2 Equal arrow 2 Less Arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 54.3% More Arrow 70.8% More Arrow 95.4%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -54.1% More Arrow -41.7% More Arrow -5.2%
Current ratio 218.9% More Arrow 339.0% More Arrow 2168.8%
Return on equity (ROE) -100.0% More Arrow -59.3% More Arrow -5.4%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees 0 More Arrow 1 Less Arrow 0
Chg. No. of employees % 0% More Arrow 100% Less Arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.